5,7-Dihydroxytryptamine lesion of the dorsal raphe nucleus alters neuronal activity of the subthalamic nucleus in normal and 6-hydroxydopamine-lesioned rats

Brain Research

Volumn 1149, Issue 1, 2007, Pages 216-222

  Liu, Jian ^a,b   Chu, Yu Xia ^a   Zhang, Qiao Jun ^a   Wang, Shuang ^a   Feng, Jie ^a   Li, Qiang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

5,7 dihydroxytryptamine; 6 hydroxydopamine; Dorsal raphe nucleus; Extracellular recording; Parkinson's disease; Subthalamic nucleus

Indexed keywords

5,7 DIHYDROXYTRYPTAMINE; OXIDOPAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN STEM INJURY; CELL ACTIVITY; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS;

5,7-DIHYDROXYTRYPTAMINE; ADRENERGIC AGENTS; ANIMALS; IMMUNOHISTOCHEMISTRY; MALE; MICROELECTRODES; NEURAL PATHWAYS; NEURONS; OXIDOPAMINE; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN AGENTS; SUBTHALAMIC NUCLEUS;

RATTUS;

EID: 34247526453     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.02.052     Document Type: Article

References (41)

1. Adell A., Celada P., Abellan M.T., and Artigas F. Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei. Brain Res. Rev. 39 (2002) 154-180
2. Barwick V.S., Jones D.H., Richter J.T., Hicks P.B., and Young K.A. Subthalamic nucleus microinjections of 5-HT2 receptor antagonists suppress stereotypy in rats. NeuroReport 11 (2000) 267-270
3. Belforte J.E., and Pazo J.H. Turning behaviour induced by stimulation of the 5-HT receptors in the subthalamic nucleus. Eur. J. Neurosci. 19 (2004) 346-355
4. Breit S., Bouali-Benazzouz R., Benabid A.L., and Benazzouz A. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal activity of the pedunculopontine nucleus, which is reversed by the lesion of the subthalamic nucleus in the rat. Eur. J. Neurosci. 14 (2001) 1833-1842
5. Canteras N.S., Shammah-Lagnado S.J., Silva B.A., and Ricardo J.A. Afferent connections of the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the rat. Brain Res. 513 (1990) 43-59
6. Castro M.E., Pascual J., Romon T., Berciano J., Figols J., and Pazos A. 5-HT1B receptor binding in degenerative movement disorders. Brain Res. 790 (1998) 323-328
7. 3H]citalopram. Neuroscience 54 (1993) 691-699
8. 3 binding sites following a unilateral 6-hydroxydopamine lesion of the medial forebrain bundle in rats. J. Neurol. Sci. 115 (1993) 105-110
9. Dafny N., Reyes-Vazquez C., and Qiao J.T. Modification of nociceptively identified neurons in thalamic parafascicularis by chemical stimulation of dorsal raphe with glutamate, morphine, serotonin and focal dorsal raphe electrical stimulation. Brain Res. Bull. 24 (1990) 717-723
10. DeLong M.R., and Wichmann T. Deep brain stimulation for Parkinson's disease. Ann. Neurol. 49 (2001) 142-143
11. Fedrowitz M., Lindemann S., Loscher W., and Gernert M. Altered spontaneous discharge rate and pattern of basal ganglia output neurons in the circling (ci2) rat mutant. Neuroscience 118 (2003) 867-878
12. Flores G., Rosales M.G., Heranadez S., Sierra A., and Aceves J. 5-Hydroxytryptamine increases spontaneous activity of subthalamic neurons in the rat. Neurosci. Lett. 192 (1995) 17-20
13. 2C receptor binding is increased in the substantia nigra pars reticulata in Parkinson's disease. Mov. Disord. 15 (2000) 1064-1069
14. Gervais J., and Rouillard C. Dorsal raphe stimulation differentially modulates dopaminergic neurons in the ventral tegmental area and substantia nigra. Synapse 35 (2000) 281-291
15. Halliday G.M., Blumbergs P.C., Cotton R.G.H., Blessing W.W., and Geffen L.B. Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease. Brain Res. 510 (1990) 104-107
16. Hamani C., Saint-Cyr J.A., Fraser J., Kaplitt M., and Lozano A.M. The subthalamic nucleus in the context of movement disorders. Brain 127 (2004) 4-20
17. Hassani O.K., Mouroux M., and Feger J. Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus. Neuroscience 72 (1996) 105-115
18. Hassani O.K., Francois C., Yelnik J., and Feger J. Evidence for a dopaminergic innervation of the subthalamic nucleus in the rat. Brain Res. 749 (1997) 88-94
19. Jacobs B.L., and Azmitia E.C. Structure and function of the brain serotonin system. Physiol. Rev. 72 (1992) 165-229
20. Jacobs B.L., and Fornal C.A. Serotonin and motor activity. Curr. Opin. Neurobiol. 7 (1997) 820-825
21. Koyama Y., and Kayama Y. Mutual interactions among cholinergic, noradrenergic and serotonergic neurons studied by ionophoresis of these transmitters in rat brainstem nuclei. Neuroscience 55 (1993) 1117-1126
22. Mehta A., Eberle-Wang K., and Chesselet M.F. Increased m-CPP-induced oral dyskinesia after lesion of serotonergic neurons. Pharmacol. Biochem. Behav. 68 (2001) 347-353
23. Mori S., Takino T., Yamada H., and Sano Y. Immunohistochemical demonstration of serotonin nerve fibres in the subthalamic nucleus of the rat, cat and monkey. Neurosci. Lett. 62 (1985) 305-309
24. Murer M.G., Riquelme L.A., Tseng K.Y., and Pazo J.H. Substantia nigra pars reticulata single unit activity in normal and 6-OHDA-lesioned rats: effects of intrastriatal apomorphine and subthalamic lesions. Synapse 27 (1997) 278-293
25. Ni Z.G., Bouali-Benazzouz R., Gao D.M., Benabid A.L., and Benazzouz A. Intrasubthalamic injection of 6-hydroxydopamine induces changes in the firing rate and pattern of subthalamic nucleus neurons in the rat. Synapse 40 (2001) 145-153
26. Ni Z.G., Bouali-Benazzouz R., Gao D.M., Benabid A.L., and Benazzouz A. Time-course of changes in firing rates and firing patterns of subthalamic nucleus neuronal activity after 6-OHDA-induced dopamine depletion in rats. Brain Res. 899 (2001) 142-147
27. Ni Z.G., Gao D.M., Bouali-Benazzouz R., Benabid A.L., and Benazzouz A. Effect of microiontophoretic application of dopamine on subthalamic nucleus neuronal activity in normal rats and in rats with unilateral lesion of the nigrostriatal pathway. Eur. J. Neurosci. 14 (2001) 373-381
28. Obeso J.A., Rodriguez M.C., Guridi J., Alvarez L., Alvarez E., Macias R., Juncos J.L., and DeLong M. Lesion of the basal ganglia and surgery for Parkinson disease. Arch. Neurol. 58 (2001) 1165-1166
29. Olijslagers J.E., Werkman T.R., McCreary A.C., Siarey R., Kruse C.G., and Wadman W.J. 5-HT2 receptors differentially modulate dopamine-mediated auto-inhibition in A9 and A10 midbrain areas of the rat. Neuropharmacology 46 (2004) 504-510
30. Parent A., and Hazrati L.N. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res. Rev. 20 (1995) 128-154
31. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. fourth ed. (1998), Academic Press, California, USA
32. Piallat B., Benazzouz A., and Benabid A.L. Subthalamic nucleus lesion in rat prevents dopaminergic nigra neuron degeneration after striatal 6-OHDA injection: behavioral and immunohistochemical studies. Eur. J. Neurosci. 8 (1996) 1408-1414
33. Plenz D., and Kital S.T. A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus. Nature 400 (1999) 677-682
34. 2C receptors. Mol. Brain Res. 23 (1994) 163-178
35. Puig M.V., Artigas F., and Celada P. Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA. Cereb. Cortex 15 (2005) 1-14
36. 1B receptors on globus pallidus neuronal spiking. Brain Res. 1043 (2005) 186-194
37. Scarnati E., Gasbarri A., Campana E., and Pacitti C. The organization of nucleus tegmenti pedunculopontinus neurons projecting to basal ganglia and thalamus: a retrograde fluorescent double labeling study in the rat. Neurosci. Lett. 79 (1987) 11-16
38. Scatton B., Javoy-Agid F., Rouquier L., Dubois B., and Agid Y. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res. 275 (1983) 321-328
39. Scholtissen B., Verhey F.R., Steinbusch H.W., and Leentjens A.F. Serotonergic mechanisms in Parkinson's disease: opposing results from preclinical and clinical data. J. Neural Transm. 113 (2006) 59-73
40. Xiang Z.X., Wang L., and Kitai S.T. Modulation of spontaneous firing in rat subthalamic neurons by 5-HT receptor subtypes. J. Neurophysiol. 93 (2005) 1145-1157
41. Zhu Z., Bartol M., Shen K., and Johnson S.W. Excitatory effects of dopamine on subthalamic nucleus neurons: in vitro study of rats pretreated with 6-hydroxydopamine and levodopa. Brain Res. 945 (2002) 31-40